Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aneuploidy screening: what test should I use?

Richard L Berkowitz1, Howard S Cuckle, Ronald Wapner

  • 1Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10128, USA. rb2212@columbia.edu

Obstetrics and Gynecology
|March 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of Discrimination and DNA Methylation Among Black Nulliparous Women.

Journal of racial and ethnic health disparities·2026
Same author

Childhood neurodevelopmental outcomes following hypertensive disorders of pregnancy.

Pregnancy hypertension·2026
Same author

Epigenome-wide DNA methylation and spontaneous preterm birth among pregnant black women.

Clinical epigenetics·2026
Same author

Maternal Outcomes Associated With a Statewide Obstetric Hemorrhage Quality-Improvement Initiative.

Obstetrics and gynecology·2026
Same author

Overdose, Homicide, and Suicide as Causes of Maternal Death in the United States.

The New England journal of medicine·2026
Same author

Balancing How Much We Want to Know with What We Are Willing to Pay: A Comparative Cost Analysis of Prenatal Cytogenetic Testing and Screening Strategies.

Fetal diagnosis and therapy·2025
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

Screening for fetal aneuploidy risk is effective in either trimester. Combining first and second trimester screening offers enhanced accuracy through integrated, stepwise, sequential, or contingency approaches.

Area of Science:

  • Maternal-fetal medicine
  • Prenatal diagnostics
  • Genetics

Background:

  • Fetal aneuploidy screening is crucial for identifying chromosomal abnormalities.
  • First and second trimester screenings offer independent risk assessments.
  • Combining data from both trimesters can potentially improve screening effectiveness.

Purpose of the Study:

  • To define and discuss various combined screening strategies for fetal aneuploidy risk.
  • To evaluate the advantages and disadvantages of integrated, stepwise, sequential, and contingency screening methods.
  • To provide a comprehensive overview of enhanced prenatal risk assessment.

Main Methods:

  • Review and discussion of combined screening methodologies.
  • Analysis of integrated screening: combining first and second trimester results.

Related Experiment Videos

  • Analysis of stepwise screening: sequential testing based on initial results.
  • Analysis of sequential screening: performing tests in a specific order.
  • Analysis of contingency screening: conditional testing based on prior outcomes.

    • Main Results:

    • Independent trimester screenings provide straightforward risk interpretation.
    • Combined approaches offer enhanced effectiveness in fetal aneuploidy risk assessment.
    • Integrated, stepwise, sequential, and contingency methods present unique benefits and drawbacks.
    • The choice of screening strategy impacts overall diagnostic accuracy and clinical utility.

    Conclusions:

    • Combining first and second trimester screening data enhances fetal aneuploidy risk assessment.
    • Different combined screening strategies (integrated, stepwise, sequential, contingency) have distinct advantages and disadvantages.
    • Optimal screening strategy selection depends on clinical context and desired performance characteristics.
    • Further research may refine the application and interpretation of combined screening protocols.